SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization. Malaria. Fact Sheet No. 94. Last updated December 2011. Available at: http://www.who.int/mediacentre/factsheets/fs094/en/index.html. (Accessed 2012 Feb 5)
  • 2
    Owen R, Roche P, Hope K, et al. Australia's notifiable disease status 2005: Annual Report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2007; 31:170.
  • 3
    Begg K, Roche P, Owen R, et al. Australia's notifiable disease status 2006: Annual Report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2008; 32:139207.
  • 4
    Liu C, for the NNDSS Annual Report Writing Group. Australia's notifiable disease status 2007: Annual Report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2009; 33:89154.
  • 5
    Liu C, for the NNDSS Annual Report Writing Group. Australia's notifiable disease status 2008: Annual Report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2010; 34:157225.
  • 6
    Sloan-Gardner T, for the NNDSS Annual Report Writing Group. Australia's notifiable disease status 2009: Annual Report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2011; 35:61131.
  • 7
    Charles DM, Hart J, Davis WA, et al. Notifications of imported malaria in Western Australia, 1990–2001: incidence, associated factors and chemoprophylaxis. Med J Aust 2005; 182:164167.
  • 8
    Lewis SJ, Davidson RN, Ross EJ, Hall AP. Severity of imported malaria: Effect of taking antimalarial prophylaxis. BMJ 1992; 305:741743.
  • 9
    Nan Tie R. Malaria in Australia: current trends and future risks. Ann Australas Coll Trop Med 2009; 10:3437.
  • 10
    Antibiotic Expert Group. Therapeutic guidelines: antibiotic. Version 12. North Melbourne: Therapeutic Guidelines Limited, 2003.
  • 11
    Antibiotic Expert Group. Therapeutic guidelines: antibiotic. Version 13. North Melbourne: Therapeutic Guidelines Limited, 2006.
  • 12
    Leggat PA. Trends in antimalarial prescription in Australia 1998–2002. J Travel Med 2005; 12:338342.
  • 13
    Leggat PA. Trends in antimalarial prescriptions in Australia 2002–2005. J Travel Med 2008; 15:302306.
  • 14
    Australian Bureau of Statistics. 3401.0 Overseas Arrivals and Departures, Australia, December 2009. Available at: http://www.abs.gov.au/AUSSTATS/abs@.nsf/allprimarymainfeatures/173F489760B4D07FCA2576DC001460F7?opendocument. (Accessed 2012 Feb 5)
  • 15
    Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian statistics on medicines 2004–2005. Canberra: Commonwealth of Australia, 2007.
  • 16
    Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian statistics on medicines 2006. Canberra: Commonwealth of Australia, 2008.
  • 17
    Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian statistics on medicines 2007. Canberra: Commonwealth of Australia, 2009.
  • 18
    Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian statistics on medicines 2008. Canberra: Commonwealth of Australia, 2010.
  • 19
    Pharmaceutical Benefits Advisory Committee, Drug Utilization Sub-Committee. Australian statistics on medicines 2009. Canberra: Commonwealth of Australia, 2011.
  • 20
    Leggat PA, Heydon JL. Trends in antimalarial drugs prescribed in New Zealand 1993–1998. J Travel Med 2002; 9:156159.
  • 21
    Leggat PA, Dürrheim DN, Blumberg L. Trends in malaria chemoprophylaxis prescription in South Africa 1994–2000. J Travel Med 2002; 9:318321.
  • 22
    DePetrillo JC, Singer C, Bergagnini IA, et al. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers. J Travel Med 2010; 17:217220.
  • 23
    Boggild AK, Parise ME, Lewis LS, Kain K. Atovaquone-Proguanil: report from the CDC Expert Meeting on malaria chemoprophylaxis. Am J Trop Med Hyg 2007; 76:208223.
  • 24
    Chen LH, Wilson ME, Schlagenhauf P. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA 2007; 297:22512263.
  • 25
    Ingram RJ, Ellis-Pegler RJ. Malaria, mefloquine and the mind. NZ Med J 1997; 110:137138.
  • 26
    World Health Organization. International travel and health. Geneva: WHO, 2012. Available at: http://www.who.int/ith. (Accessed 2012 Aug 2)
  • 27
    Therapeutic Goods Administration. Orphan drugs. Last updated 6 July 2011. Available at: http://www.tga.gov.au/industry/pm-orphan-drugs.htm. (Accessed 2012 Feb 5)
  • 28
    World Health Organization. Guidelines for the treatment of malaria. 2nd Ed. Geneva: WHO, 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf. (Accessed 2012 Feb 05)